A New Jersey jury on Tuesday found that Swiss drugmaker Roche Holding AG failed to adequately warn a patient of the bowel disease risks associated with its acne medicine Accutane and awarded him $2.5 million in damages.
From: news.yahoo.com
U.S. jury awards $2.5 mln in Roche Accutane trial
Posted by Ruslan Abuzant at 2:26 PM
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment